Exclusion Criteria:~* Current evidence of other causes of dementia.~* History or evidence of, active
malignancy, except for basal cell carcinoma or squamous cell carcinoma of the skin, within the 24 months prior
to entry. Men with prostate cancer may be enrolled at the discretion of the sponsor.~* Chronic or acute renal,
hepatic or metabolic disorder.~* Use of any investigational therapy within 30 days, or 5 half-lives, whichever
is longer, and/or use of AD immunotherapy prior to screening.~* Major surgery and related complications not
resolved within 12 weeks prior to Day 1.
